Ernexa Therapeutics (ERNA) Return on Assets (2016 - 2025)
Historic Return on Assets for Ernexa Therapeutics (ERNA) over the last 15 years, with Q3 2025 value amounting to 2.67%.
- Ernexa Therapeutics' Return on Assets fell 10100.0% to 2.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.67%, marking a year-over-year decrease of 10100.0%. This contributed to the annual value of 1.64% for FY2024, which is 10300.0% down from last year.
- According to the latest figures from Q3 2025, Ernexa Therapeutics' Return on Assets is 2.67%, which was down 10100.0% from 6.92% recorded in Q2 2025.
- Over the past 5 years, Ernexa Therapeutics' Return on Assets peaked at 0.4% during Q3 2023, and registered a low of 8.93% during Q1 2025.
- Its 5-year average for Return on Assets is 2.58%, with a median of 1.5% in 2021.
- Its Return on Assets has fluctuated over the past 5 years, first soared by 40300bps in 2023, then crashed by -84700bps in 2025.
- Over the past 5 years, Ernexa Therapeutics' Return on Assets (Quarter) stood at 2.06% in 2021, then soared by 45bps to 1.14% in 2022, then surged by 62bps to 0.43% in 2023, then crashed by -1505bps to 6.86% in 2024, then soared by 61bps to 2.67% in 2025.
- Its Return on Assets stands at 2.67% for Q3 2025, versus 6.92% for Q2 2025 and 8.93% for Q1 2025.